Trials / Unknown
UnknownNCT04274231
Cancer-associated Gene Mutations in CML Treatment With TKIs by NGS
Integrative Genomic Analysis Reveals Cancer-associated Gene Mutations in Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance or Intolerance
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
We performed targeted-capture sequencing of 127 known and putative cancer-related genes of patients who best effect to TKIs ,or intolerance to TKIs,or resistance to TKIs by next-generation sequencing (NGS) .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | different effection | Analysis of the reasons for treatment |
Timeline
- Start date
- 2020-02-16
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2020-02-18
- Last updated
- 2022-04-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04274231. Inclusion in this directory is not an endorsement.